Deucravacitinib treatment did not affect immune response to SARS-Cov-2 vaccines and infection in patients with plaque psoriasis: results from the Phase 3 POETYK long-term extension trial

被引：0
|
作者：
不详
机构：
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 191卷
关键词：
D O I：
10.1093/bjd/ljae360.144
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P114
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Absence of Pericarditis Recurrence in Rilonacept-Treated Patients With COVID-19 and SARS-CoV-2 Vaccination: Results From the RHAPSODY Long-term Extension
    Brucato, Antonio
    Trotta, Lucia
    Arad, Michael
    Cremer, Paul C.
    Insalaco, Antonella
    Klutstein, Marc
    LeWinter, Martin
    Lin, David
    Luis, Sushil A.
    Wasserstrum, Yishay
    Clair, JoAnn
    Wang, Sheldon
    Klein, Allan L.
    Imazio, Massimo
    Paolini, John F.
    CJC OPEN, 2024, 6 (06) : 805 - 810
  • [32] Long-Term Immune Response Profiles to SARS-CoV-2 Vaccination and Infection in People with Multiple Sclerosis on Anti-CD20 Therapy
    Woopen, Christina
    Dunsche, Marie
    Al Rahbani, Georges Katoul
    Dillenseger, Anja
    Atta, Yassin
    Haase, Rocco
    Raposo, Catarina
    Pedotti, Rosetta
    Ziemssen, Tjalf
    Akgun, Katja
    VACCINES, 2023, 11 (09)
  • [33] Long-term Follow-up Results of Tinnitus and Dizziness Disorders in Patients after SARS-CoV-2 Infection Based on a Questionnaire
    Aliyeva, Aynur
    Han, Jae Sang
    Park, Shi Nae
    Olgun, Levent
    BALKAN MEDICAL JOURNAL, 2023, 40 (01) : 70 - 71
  • [34] Bimekizumab efficacy and safety through 3 years in patients with moderate-to-severe plaque psoriasis: long-term results from the BE RADIANT phase IIIb trial open-label extension period
    Warren, Richard B.
    Lebwohl, Mark
    Thaci, Diamant
    Gooderham, Melinda
    Pinter, Andreas
    Paul, Carle
    Gisondi, Paolo
    Szilagyi, Balint
    White, Katy
    Deherder, Delphine
    Staelens, Fabienne
    Lambert, Jeremy
    Strober, Bruce
    BRITISH JOURNAL OF DERMATOLOGY, 2025,
  • [35] Bimekizumab efficacy and safety through 3 years in patients with moderate to severe plaque psoriasis: Long-term results from the BE SURE trial and BE BRIGHT open-label extension
    Sinclair, Rodney
    Thaci, Diamant
    Vender, Ronald
    de Rie, Menno
    Conrad, Curdin
    Soung, Jennifer
    Strober, Bruce
    Wang, Maggie
    Cross, Nancy
    Deherder, Delphine
    Gomez, Natalie Nunez
    Gottlieb, Alice B.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 18 - 18
  • [36] Long-term efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 5-year extension of a phase 3 study (reSURFACE 1)
    Imafuku, Shinichi
    Nakagawa, Hidemi
    Igarashi, Atsuyuki
    Morita, Akimichi
    Okubo, Yukari
    Sano, Shigetoshi
    Tada, Yayoi
    Nemoto, Osamu
    Rozzo, Stephen J.
    Kawamura, Masaki
    Ohtsuki, Mamitaro
    JOURNAL OF DERMATOLOGY, 2021, 48 (06): : 844 - 852
  • [37] Safety and durability of mRNA-1273-induced SARS-CoV-2 immune responses in adolescents: results from the phase 2/3 TeenCOVE trial
    Figueroa, Amparo L.
    Ali, Kashif
    Berman, Gary
    Zhou, Honghong
    Deng, Weiping
    Xu, Wenqin
    Lussier, Stephanie
    Girard, Bethany
    Dutko, Frank J.
    Slobod, Karen
    Yeakey, Anne
    Priddy, Frances
    Miller, Jacqueline M.
    Das, Rituparna
    ECLINICALMEDICINE, 2024, 74
  • [38] Efficacy and safety of infliximab as continuous or intermittent therapy in patients with moderate-to-severe plaque psoriasis: results of a randomized, long-term extension trial (RESTORE2)
    Reich, K.
    Wozel, G.
    Zheng, H.
    van Hoogstraten, H. J. F.
    Flint, L.
    Barker, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (06) : 1325 - 1334
  • [39] Updates on COVID-19 cases and SARS-CoV-2 vaccinations during tralokinumab treatment in moderate-to-severe atopic dermatitis from ECZTEND long-term extension trial
    Langley, R.
    Pink, A.
    Worm, M.
    Costanzo, A.
    Gjerum, L.
    Jorgensen, E.
    Corriveau, J.
    Schneider, S.
    Guttman-Yassky, E.
    Blauvelt, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E144 - E145
  • [40] Blood microbial analyses reveal long-term effects of SARS-CoV-2 infection on patients who recovered from COVID-19
    Wang, Ping
    Zhang, Sainan
    Qi, Changlu
    Wang, Chao
    Zhu, Zijun
    Shi, Lei
    Cheng, Liang
    Zhang, Xue
    COMPUTERS IN BIOLOGY AND MEDICINE, 2024, 168
12345